Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : HALEOSLABSBSE : 540679ISIN CODE : INE320X01016Industry : Pharmaceuticals & DrugsHouse : Private

BSE1299.0045.2 (+3.61 %)

PREV CLOSE ( ) 1253.80

OPEN PRICE ( ) 1299.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1

TODAY'S LOW / HIGH ( )1299.00 1299.00

52 WK LOW / HIGH ( )1050.05 1680

NSE1287.7033.9 (+2.7 %)

PREV CLOSE( ) 1253.80

OPEN PRICE ( ) 1197.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 603

TODAY'S LOW / HIGH( ) 1197.60 1290.00

52 WK LOW / HIGH ( )1029.05 1680

Managing Director	TVVSN Murthy
Company Secretary	Trupti Ranjan Mohanty
Executive Director	T V Praveen
Non Executive Independent Director	P Sarath Kumar Mannam Malakondaiah Srinivas Samavedam Sundaramma Patibandla
Whole Time Director	Sudeepthi Gopineedi

Incorporation Year : 31-05 2006

Registered Office :

Address : Plot No 19 – I I I, Road No 71,Opp. Bharatiya Vidya Bhavan Public School,Jubilee Hills Hyderabad,
Telangana-500096 .

Phone : 040-66288888

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE